Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0088 Transporter Info
Gene Name	SLC12A7
Transporter Name	Electroneutral potassium-chloride cotransporter 4
Gene ID	10723
UniProt ID	Q9Y666

Post-Translational Modification of This DT
Overview of SLC12A7 Modification Sites with Functional and Structural Information
Sequence	M P T N F T V V P V E A H A D G G G D E T A E R T E A P G T P E G P E P E R P S P G D G N P R E N S P F L N N V E V E Q E S F F E G K N M A L F E E E M D S N P M V S S L L N K L A N Y T N L S Q G V V E H E E D E E S R R R E A K A P R M G T F I G V Y L P C L Q N I L G V I L F L R L T W I V G V A G V L E S F L I V A M C C T C T M L T A I S M S A I A T N G V V P A G G S Y Y M I S R S L G P E F G G A V G L C F Y L G T T F A G A M Y I L G T I E I F L T Y I S P G A A I F Q A E A A G G E A A A M L H N M R V Y G T C T L V L M A L V V F V G V K Y V N K L A L V F L A C V V L S I L A I Y A G V I K S A F D P P D I P V C L L G N R T L S R R S F D A C V K A Y G I H N N S A T S A L W G L F C N G S Q P S A A C D E Y F I Q N N V T E I Q G I P G A A S G V F L E N L W S T Y A H A G A F V E K K G V P S V P V A E E S R A S A L P Y V L T D I A A S F T L L V G I Y F P S V T G I M A G S N R S G D L K D A Q K S I P T G T I L A I V T T S F I Y L S C I V L F G A C I E G V V L R D K F G E A L Q G N L V I G M L A W P S P W V I V I G S F F S T C G A G L Q S L T G A P R L L Q A I A R D G I V P F L Q V F G H G K A N G E P T W A L L L T V L I C E T G I L I A S L D S V A P I L S M F F L M C Y L F V N L A C A V Q T L L R T P N W R P R F K F Y H W T L S F L G M S L C L A L M F I C S W Y Y A L S A M L I A G C I Y K Y I E Y R G A E K E W G D G I R G L S L N A A R Y A L L R V E H G P P H T K N W R P Q V L V M L N L D A E Q A V K H P R L L S F T S Q L K A G K G L T I V G S V L E G T Y L D K H M E A Q R A E E N I R S L M S T E K T K G F C Q L V V S S S L R D G M S H L I Q S A G L G G L K H N T V L M A W P A S W K Q E D N P F S W K N F V D T V R D T T A A H Q A L L V A K N V D S F P Q N Q E R F G G G H I D V W W I V H D G G M L M L L P F L L R Q H K V W R K C R M R I F T V A Q V D D N S I Q M K K D L Q M F L Y H L R I S A E V E V V E M V E N D I S A F T Y E R T L M M E Q R S Q M L K Q M Q L S K N E Q E R E A Q L I H D R N T A S H T A A A A R T Q A P P T P D K V Q M T W T R E K L I A E K Y R S R D T S L S G F K D L F S M K P D Q S N V R R M H T A V K L N G V V L N K S Q D A Q L V L L N M P G P P K N R Q G D E N Y M E F L E V L T E G L N R V L L V R G G G R E V I T I Y S
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	312
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC12A7 Asparagine 312 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	360
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC12A7 Asparagine 360 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	762
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC12A7 Cystine 762 has the potential to affect its expression or activity.
Phosphorylation
Serine	17 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	40
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 40 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	50
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 50 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	62
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 62 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A7			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	78
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 78 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A7			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	83
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 83 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A7			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 84 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A7			[7] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	96
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 96 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A7			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	108
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 108 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A7			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	669
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 669 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A7			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	780
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 780 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A7			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	798
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 798 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A7			[6] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	933
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 933 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A7			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	960
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 960 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A7			[6] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	993
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 993 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A7			[10] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	997
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 997 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A7			[10] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	999
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 999 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC12A7			[9] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1006
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Serine 1006 has the potential to affect its expression or activity.
Threonine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	3
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 3 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	6
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 6 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[18] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 21 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A7			[4] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	25
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 25 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A7			[14] , [22]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	30
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 30 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A7			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	93
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 93 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A7			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	790
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 790 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A7			[17] , [25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	926
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 926 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A7			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	958
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 958 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A7			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	962
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 962 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A7			[3] , [16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	968
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 968 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A7			[3] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	973
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 973 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A7			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	980
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 980 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A7			[3] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	982
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 982 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A7			[10] , [17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	996
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Threonine 996 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[24] , [28]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	92
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Tyrosine 92 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[29] , [30]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	991
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A7 Tyrosine 991 has the potential to affect its expression or activity.
Ubiquitination
Alanine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	824
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Alanine 824 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[29] , [31]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	966
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Alanine 966 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	988
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Alanine 988 has the potential to affect its expression or activity.
Arginine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	674
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Arginine 674 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[29] , [31]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	875
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Arginine 875 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[32]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	983
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Arginine 983 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	994
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Arginine 994 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A7			[32]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	1048
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Arginine 1048 has the potential to affect its expression or activity.
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	916
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Asparagine 916 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[29] , [33]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1013
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Asparagine 1013 has the potential to affect its expression or activity.
Asparticacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	917
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Asparticacid 917 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[32]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	1051
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Asparticacid 1051 has the potential to affect its expression or activity.
Glutamicacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[33]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	377
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glutamicacid 377 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	915
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glutamicacid 915 has the potential to affect its expression or activity.
Glutamine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	890
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glutamine 890 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	934
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glutamine 934 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	940
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glutamine 940 has the potential to affect its expression or activity.
Glycine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[33]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	442
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glycine 442 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	1025
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glycine 1025 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[32]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	1074
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Glycine 1074 has the potential to affect its expression or activity.
Isoleucine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	878
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Isoleucine 878 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	889
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Isoleucine 889 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[29] , [33]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	987
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Isoleucine 987 has the potential to affect its expression or activity.
Leucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	711
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Leucine 711 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	825
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Leucine 825 has the potential to affect its expression or activity.
Lysine	16 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing cell surface expression of SLC12A7			[34]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	976
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 976 have been reported to decrease its cell surface expression.
PTM Phenomenon 2	Decreasing cell surface expression of SLC12A7			[34]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	990
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 990 have been reported to decrease its cell surface expression.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[33]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	445
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 445 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	688
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 688 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A7			[35]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	757
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 757 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A7			[36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	800
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 800 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A7			[35]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	809
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 809 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A7			[29] , [31]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	869
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 869 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	892
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 892 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	893
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 893 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	937
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 937 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	943
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 943 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	985
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 985 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1002
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 1002 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1008
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 1008 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A7			[32]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1046
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Lysine 1046 has the potential to affect its expression or activity.
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29] , [31]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	929
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Methionine 929 has the potential to affect its expression or activity.
Phenylalanine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	620
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Phenylalanine 620 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	879
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Phenylalanine 879 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	1005
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Phenylalanine 1005 has the potential to affect its expression or activity.
Proline	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	685
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Proline 685 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	971
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Proline 971 has the potential to affect its expression or activity.
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[33]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	468
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Serine 468 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[29] , [31]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	960
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Serine 960 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	999
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Serine 999 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1031
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Serine 1031 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29] , [33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	922
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Threonine 922 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	962
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Threonine 962 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	973
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Threonine 973 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A7			[29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	982
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Threonine 982 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[29] , [31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	923
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Tyrosine 923 has the potential to affect its expression or activity.
Valine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A7			[33]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	431
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Valine 431 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	908
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Valine 908 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A7			[32]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	1037
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A7 Valine 1037 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S12A7_HUMAN)
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
4	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
5	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
6	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
7	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
8	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
9	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
10	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
12	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
13	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
14	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
15	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
16	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
17	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
18	Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2918-27.
19	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
20	Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer. J Proteome Res. 2013 Sep 6;12(9):4089-100.
21	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
22	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
23	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
24	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
25	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
26	Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
27	The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 Aug 6;182(3):685-712.e19.
28	Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
29	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
30	Wide-scale quantitative phosphoproteomic analysis reveals that cold treatment of T cells closely mimics soluble antibody stimulation. J Proteome Res. 2015 May 1;14(5):2082-9.
31	Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol. 2012 Oct;14(10):1089-98.
32	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
33	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
34	Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell Biosci. 2021 Apr 17;11(1):75.
35	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
36	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.
37	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
38	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence